raloxifene hydrochloride has been researched along with Back Pain in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chhabra, H; Mumtaz, M; Songpatanasilp, T; Sorsaburu, S; Yu, M | 1 |
| Fujii, Y; Fujita, T; Munezane, H; Ohue, M; Takagi, Y | 1 |
| Barker, C; Brixen, K; del Pino, J; Farrerons, J; Keen, R; Lyritis, G; Marin, F; Nickelsen, TN; Pfeifer, M | 1 |
| Damilakis, J; Hadjipavlou, A; Katonis, P; Papadokostakis, G | 1 |
| Helsberg, K; Kessler, F; Langer, F; Nickelsen, T; Oertel, H; Scharla, S | 1 |
| Gold, DT; Silverman, SL | 1 |
3 trial(s) available for raloxifene hydrochloride and Back Pain
| Article | Year |
|---|---|
Analgesic effect of raloxifene on back and knee pain in postmenopausal women with osteoporosis and/or osteoarthritis.
Topics: Aged; Arthralgia; Back Pain; Bone Density Conservation Agents; Female; Humans; Knee Joint; Middle Aged; Osteoarthritis; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride | 2010 |
Back pain during different sequential treatment regimens of teriparatide: results from EUROFORS.
Topics: Aged; Back Pain; Bone Density Conservation Agents; Calcium; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Pain Measurement; Raloxifene Hydrochloride; Spinal Fractures; Teriparatide; Treatment Outcome; Vitamin D | 2010 |
Does raloxifene treatment influence back pain and disability among postmenopausal women with osteoporosis?
Topics: Back Pain; Calcium; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Motor Activity; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Vitamin D | 2005 |
3 other study(ies) available for raloxifene hydrochloride and Back Pain
| Article | Year |
|---|---|
Back pain in patients with severe osteoporosis on teriparatide or antiresorptives: a prospective observational study in a multiethnic population.
Topics: Aged; Back Pain; Bone Density Conservation Agents; Diphosphonates; Ethnicity; Female; Humans; International Cooperation; Male; Middle Aged; Osteoporosis; Prospective Studies; Quality of Life; Raloxifene Hydrochloride; Surveys and Questionnaires; Teriparatide; Time Factors; Treatment Outcome | 2014 |
Skeletal pain in postmenopausal women with osteoporosis: prevalence and course during raloxifene treatment in a prospective observational study of 6 months duration.
Topics: Aged; Analgesics; Arthralgia; Back Pain; Bone Density; Bone Density Conservation Agents; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Prevalence; Prospective Studies; Raloxifene Hydrochloride; Sleep | 2006 |
Do estrogen or selective estrogen receptor modulators improve quality of life for women with postmenopausal osteoporosis?
Topics: Aged; Aged, 80 and over; Back Pain; Estrogens; Fatigue; Female; Fractures, Spontaneous; Hip Fractures; Humans; Middle Aged; Osteoporosis, Postmenopausal; Postmenopause; Prevalence; Quality of Life; Raloxifene Hydrochloride; Risk Factors; Selective Estrogen Receptor Modulators; Spinal Fractures; Tamoxifen; United States | 2007 |